ReviewBritish journal of pharmacology2011

The case for peripheral CB₁ receptor blockade in the treatment of visceral obesity and its cardiometabolic complications.

George Kunos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.